|
2017 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyà s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartÃn, MarÃa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
abril 2012 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
2014 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
5 juny 2018 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
5 juny 2018 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
20 maig 2015 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
15 febrer 2020 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|